Form 4: Oscar Health Executive Ranmali Bopitiya Reports Stock Sales and RSU Vesting

Sentiment:

SEC Form 4


Ranmali Bopitiya, EVP & Chief Legal Officer of Oscar Health, reports the vesting of restricted stock units and subsequent sale of Class A Common Stock to cover tax obligations.

Summary

  • On September 4, 2024, Ranmali Bopitiya, EVP & Chief Legal Officer of Oscar Health, filed a Form 4 detailing transactions in the company's Class A Common Stock.
  • The transactions included the vesting of restricted stock units (RSUs) and the subsequent sale of shares to cover tax withholding obligations.
  • On September 1, 2024, 132,677 RSUs vested, converting into Class A Common Stock.
  • Bopitiya sold 36,175 shares on September 3, 2024, at a weighted average price of $17.99.
  • Additional sales occurred on September 4, 2024, with 18,158 shares sold at $17.46 and 14,820 shares sold at $17.85.
  • These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted before February 27, 2023.
  • Following these transactions, Bopitiya directly owns 218,907 shares of Class A Common Stock and holds 164,474 Restricted Stock Units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transactions are routine and related to tax obligations, not necessarily indicative of a change in the executive's confidence in the company.

Positives

  • The transactions are part of a pre-arranged trading plan (Rule 10b5-1), suggesting they were planned well in advance and not based on current insider information.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects. However, sales to cover tax obligations are routine and may not reflect a change in sentiment.

Comparison to Industry Standards

  • Executive compensation packages often include restricted stock units that vest over time.
  • Sales of stock to cover tax obligations upon vesting are a standard practice among executives in publicly traded companies.
  • Rule 10b5-1 trading plans are widely used by corporate insiders to schedule stock sales in advance, mitigating concerns about trading on non-public information.
  • Comparable companies such as Alignment Healthcare and Bright Health Group also see regular Form 4 filings related to executive stock transactions.

Stakeholder Impact

  • The stock sales may have a minor, short-term impact on the stock price, but the overall impact on stakeholders is likely to be minimal given the routine nature of the transactions.

Key Dates

DateDescription
January 14, 2022Date of Power of Attorney execution.
June 1, 2022Start date for vesting of 20,425 restricted stock units over a four-year period.
February 27, 2023Date before which the Rule 10b5-1 trading plan was entered into.
June 1, 2023Start date for vesting of 16,448 restricted stock units over a four-year period.
June 1, 2024Start date for vesting of 4,867 restricted stock units over a three-year period.
September 1, 2024Vesting date for 132,677 restricted stock units.
September 3, 2024Sale of 36,175 shares of Class A Common Stock at a weighted average price of $17.99.
September 4, 2024Sale of 18,158 shares of Class A Common Stock at a weighted average price of $17.46 and 14,820 shares at $17.85.
September 4, 2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.